This bill allows pharmacists to prescribe medications that help people quit smoking, provided they have completed specific state-approved education on tobacco cessation therapies. It directly affects pharmacists and their employers by establishing new prescribing authority within their professional scope. The legislation requires pharmacists to complete education approved by the state board of pharmacy before they can use this new prescribing power. This change aims to expand access to smoking cessation treatments through pharmacies.
Includes routine, scheduled or recommended immunizations to individuals between the ages of three (3) and eighteen (18) years, under the consent and reporting provisions required for pharmacy administered immunizations.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Expands the existing law regarding collaborative practice agreements between pharmacists and physicians to allow other healthcare providers to enter into such agreements and removes the definition of “collaborative practice committee.”
This bill prohibits pharmacy benefits managers from engaging in specific deceptive trade practices, including spread pricing, effective rate pricing, and patient steering. It directly affects pharmacy benefits managers, pharmacies, pharmacists, and patients enrolled in health plans administered by these managers within Rhode Island. The legislation defines prohibited actions such as charging higher prices than reimbursed amounts, steering patients toward affiliated pharmacies, penalizing enrollees for pharmacy choices, and misusing patient prescription data for business gain. Violations are classified as unfair and deceptive trade practices, allowing the attorney general to pursue legal remedies for each individual consumer transaction where a prohibited act occurs.
This bill strengthens oversight of pharmacy benefits managers in Rhode Island by requiring them to register with the state and submit detailed annual reports about their financial relationships with insurers. It prohibits these managers from forcing pharmacies to substitute generic drugs without prescriber approval and bans them from stopping pharmacists from sharing pricing information with patients. The legislation also prevents pharmacy benefits managers from charging copayments that exceed what pharmacies are paid and mandates a clear appeals process for disputes over drug pricing. These changes directly affect pharmacy benefits managers, insurers, pharmacies, and patients who use prescription drug coverage in the state.
Requires pharmacy benefit managers to apply for certificate of authority from the office of health insurance commissioner to operate such a business in this state and empowers the commissioner to oversee pharmacy benefit managers and penalize violations.
Caps the total amount that a covered person is required to pay for a covered prescription inhaler, prescription device, or prescription equipment to twenty-five dollars ($25.00) per thirty (30) day supply.
Limits the use by insurers of step therapy, a protocol that establishes a specific sequence in which prescription drugs for a specified medical condition are covered by an insurer, by allowing medical providers to request step therapy exceptions.